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Idiopathic Parkinson’s disease phenotype related
to C9ORF72 repeat expansions: contribution of
the neuropsychological assessment
Mariam Annan1,2, Émilie Beaufils2,3,4, Ursule-Catherine Viola1, Patrick Vourc’h2,5,6, Caroline Hommet2,3,4,5
and Karl Mondon2,3,4,5*
Abstract
Background: Expanded GGGGCC hexanucleotide repeats in the non-coding region of the C9ORF72 gene was
recently identified as being responsible for over 40% of the cases of amyotrophic lateral sclerosis associated with
frontotemporal lobar degeneration, in various extrapyramidal syndromes including supranuclear gaze palsy and
corticobasal degeneration, and in addition, has been found to be a rare genetic cause of isolated Parkinsonism. To
our knowledge, there is no published data concerning the neuropsychological evaluation of patients diagnosed
with idiopathic Parkinson’s disease related with C9ORF72 repeat expansions.
Case presentation: We report the results of the comprehensive neuropsychological evaluation in a newly
described case in the literature (the sixth) of a patient presenting isolated idiopathic Parkinson’s disease associated
with C9ORF72 repeat expansions.
The decrease in the patient’s prefrontal functions resulted in a slight decrease in global efficiency. These
abnormalities did not appear to be different, with respect to the deficit observed and the intensity of the cognitive
impairment, from those classically observed in cases of sporadic idiopathic Parkinson’s disease. Our patient also
exhibited a significant impairment in visual gnosis.
Conclusions: If confirmed in other patients, visuoperceptive deficits in idiopathic Parkinson’s disease could
represent a red flag that should prompt the clinician to perform addition diagnostic procedures. A thorough
neuropsychological assessment may prove to be useful for detecting idiopathic Parkinson’s disease in patients who
are suspected of having repeat abnormalities of C9ORF72 expansions.
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Background
Expanded GGGGCC hexanucleotide repeats in non-coding
regions of the C9ORF72 gene was recently identified as
being responsible of over 40% of the cases of amyotrophic
lateral sclerosis associated with frontotemporal lobar de-
generation [1,2].
Recent publications have shown involvement of
C9ORF72 repeat expansions in various extrapyramidal
syndromes including supranuclear gaze palsy and cor-
ticobasal degeneration [3] and has also be found to
constitute a rare genetic cause of isolated parkinsonism
[4] in some patients who fulfil the UK Parkinson’s Disease
Society Brain Bank [5] criteria for idiopathic Parkinson’s
disease (IPD).
To our knowledge, there is no published data on the
contribution of the neuropsychological assessment in
these last-mentioned patients.
We report the results of the thorough neuropsycho-
logical assessment of a newly described case in the
literature (the sixth) of a patient presenting isolated
IPD associated with C9ORF72 repeat expansions.
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Case presentation
A 63 year-old woman was referred to our department
because of a strong family history of neurological dis-
eases: her mother had died at the age of 59 years with
Alzheimer’s dementia and her two sisters had died at
age 69 and 59 y respectively with a diagnosis of fron-
totemporal lobar degeneration associated with minor
symptoms of parkinsonism. A C9ORF72 repeat expansion
was found by genetic analysis in the youngest sister.
Her personal medical history included appendectomy,
diabetes mellitus, and a complete excision of a melanoma.
Parkinsonism was first diagnosed in 2009 at the age of
63 years when left akinesia and tremor appeared. Her
symptoms responded poorly to levodopa, and the re-
sponse rate was estimated to be approximately 20% by
both the patient and her husband, and progressively
worsened. At the onset, neurological examination re-
vealed a resting tremor associated with akinesia. The
Parkinsonism was bilateral but was clearly predominant
on the left side. Rapid and alternative movements in the
left hand were severely hypometric. Her left lower extrem-
ity was also akinetic, and she had severe difficulties in
performing repetitive movements. She had no limitation
in oculomotor movements and no gait disorder. She never
developed motor fluctuations or dyskinesias. The pa-
tient fulfilled the criteria for IPD according to the UK
Parkinson’s Disease Society Brain Bank [5]: i/ the
parkinson’s syndrome was defined by bradykinesia,
with a 4–6 Hz resting tremor associated with muscular
rigidity; ii/ no exclusion criteria were observed; iii/ the
clinical presentation included more than 3 supportive
prospective criteria (unilateral onset, rest tremor, pro-
gressive clinical course, persistent asymmetry affecting
the side most affected at the onset of the disease).
A complete neuropsychological assessment two years
after the onset of the disease (2011) revealed preserva-
tion of global cognitive efficiency (MATTIS DRS score:
137/144 [6]), difficulties in the executive functions (with
a score at 10/18 on the Frontal Assessment Battery [7]),
no difficulty in mental flexibility (Trail making test [8])
or sensitivity to interference (stroop test [9]), and global
slowness (Coding subtest of the WAIS [10]).
After the discovery of the disease, we asked the patient
for permission to test for the C9ORF72 gene abnormality.
The number of repeat expansions was superior to 30 and
was therefore considered to be abnormal.
In 2012, a comprehensive neuropsychological assess-
ment was performed (see results in Table 1) and re-
vealed: a slight decrease in global cognitive efficiency
(MATTIS DRS score [6]), normal efficiency in long-
term verbal episodic (free and cued recall test [11]) and
visual (modified Taylor complex figure [12]) memories,
language (oral denomination [13]), praxis (Mahieux’s
battery [14] and visuospatial skills (Modified Taylor
complex figure - copy [12]); low scores in short-term
memory (WAIS-III digit span subtest [10]), and the
prefrontal functions including verbal initiation (verbal flu-
encies [15]), and conflicting task (stroop test [9]). Unfortu-
nately, our patient also exhibited significant difficulties in
visual gnosis (Poppelreuter [16] and PEGV [17]).
Conclusions
We report the case of a patient diagnosed with IPD
according to the usual criteria, who presented neuro-
psychological impairment early in the clinical course.
Her primary difficulties included impaired prefrontal
functions resulting in a slight decrease in global efficiency.
These abnormalities are similar, in terms of deficit and
intensity, to the cognitive impairment classically observed
in sporadic cases of IPD [18]. Our patient also exhibited
significant impairment in visual gnosis. An alteration in
Table 1 Results of the neuropsychological assessment
Cognitive domain / Neuropsychological test (Range) Score*
Global efficiency
MATTIS DRS (0–144) 133
Memory
Free and cued recall test
Immediate recall (0–16) 13
Free recall (0–48) 25
Total recall (0–48) 44
% sensitivity (0–100) 83%
WAIS-R digit span subtest (direct) 4
WAIS-R digit span subtest (reverse) 3
Modified Taylor Complex figure (memory) (0–36) 17
Language
DO-80 (0–80) 78
Letter fluency task 2 min (>0) 21
Semantic fluency task 2 min (>0) 5
Visuospatial skills
Modified Taylor Complex figure (copy) (0–36) 29
Visual gnosis
Poppelreuter (0–8) 4
PEGV (0–36) 27
Prefrontal functions
TMT A (time in s) 99
TMT B (time in s) 223
Stroop conflictual task (sec) 146
Limb praxis
Mahieux’s battery (0–20) 17
Visuomotor speed
WAIS-R coding subtest (0–133) 26
*in bold caps: abnormal scores.
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visuomotor and visuoperceptive functions have been de-
scribed in IPD, but the deficit is usually mild when it oc-
curs in non-demented patients [19]. If confirmed in other
patients, this unusually severe deficit in IPD could repre-
sent a red flag, alerting the clinician to perform additional
diagnostic procedures.
A thorough neuropsychological assessment could
prove to be useful for detecting in IPD patients who
are suspected of having C9ORF72 repeat expansions
abnormalities.
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